» Go to news main
Molly Appeal paves the way to precision cancer treatment
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
- Dal Med Innovator | Dr. Karen Mann
- Dal bioethicist urges academics to stimulate debate on hot‑button topics
- First woman in Canada to become a Dean of Medicine accepts Trailblazer Award
- Grad Profile: On a mission to improve mother and baby health around the world
- Grad Profiles: Stepping forward while looking back
- Impact Players
- Med students give community organizations a helping hand
- Dal epidemiologist shows probiotics prevent C. difficile in hospital